ICU Medical ROA 2012-2025 | ICUI
Current and historical return on assets (ROA) values for ICU Medical (ICUI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| ICU Medical ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $-0.01B | $4.10B | -0.17% |
| 2025-06-30 | $-0.04B | $4.11B | -0.88% |
| 2025-03-31 | $-0.09B | $4.19B | -2.19% |
| 2024-12-31 | $-0.12B | $4.20B | -2.74% |
| 2024-09-30 | $-0.11B | $4.31B | -2.55% |
| 2024-06-30 | $-0.07B | $4.29B | -1.62% |
| 2024-03-31 | $-0.06B | $4.29B | -1.35% |
| 2023-12-31 | $-0.03B | $4.38B | -0.68% |
| 2023-09-30 | $-0.03B | $4.38B | -0.65% |
| 2023-06-30 | $-0.05B | $4.46B | -1.09% |
| 2023-03-31 | $-0.05B | $4.47B | -1.02% |
| 2022-12-31 | $-0.07B | $4.52B | -1.62% |
| 2022-09-30 | $-0.04B | $4.45B | -0.97% |
| 2022-06-30 | $0.01B | $4.59B | 0.18% |
| 2022-03-31 | $0.04B | $4.75B | 1.60% |
| 2021-12-31 | $0.10B | $1.88B | 5.65% |
| 2021-09-30 | $0.11B | $1.84B | 6.08% |
| 2021-06-30 | $0.10B | $1.80B | 5.83% |
| 2021-03-31 | $0.09B | $1.77B | 5.28% |
| 2020-12-31 | $0.09B | $1.76B | 4.85% |
| 2020-09-30 | $0.08B | $1.73B | 4.62% |
| 2020-06-30 | $0.08B | $1.86B | 4.80% |
| 2020-03-31 | $0.09B | $1.82B | 5.20% |
| 2019-12-31 | $0.10B | $1.69B | 6.21% |
| 2019-09-30 | $0.07B | $1.64B | 4.58% |
| 2019-06-30 | $0.05B | $1.62B | 2.95% |
| 2019-03-31 | $0.06B | $1.61B | 3.51% |
| 2018-12-31 | $0.03B | $1.59B | 1.89% |
| 2018-09-30 | $0.09B | $1.55B | 5.68% |
| 2018-06-30 | $0.09B | $1.53B | 5.70% |
| 2018-03-31 | $0.02B | $1.49B | 1.20% |
| 2017-12-31 | $0.07B | $1.50B | 4.62% |
| 2017-09-30 | $0.03B | $1.52B | 2.24% |
| 2017-06-30 | $0.05B | $1.49B | 4.41% |
| 2017-03-31 | $0.10B | $1.47B | 11.56% |
| 2016-12-31 | $0.06B | $0.71B | 9.51% |
| 2016-09-30 | $0.06B | $0.69B | 9.02% |
| 2016-06-30 | $0.06B | $0.66B | 8.83% |
| 2016-03-31 | $0.05B | $0.64B | 8.68% |
| 2015-12-31 | $0.05B | $0.63B | 7.62% |
| 2015-09-30 | $0.05B | $0.61B | 8.26% |
| 2015-06-30 | $0.04B | $0.57B | 6.75% |
| 2015-03-31 | $0.03B | $0.55B | 5.41% |
| 2014-12-31 | $0.03B | $0.54B | 4.96% |
| 2014-09-30 | $0.03B | $0.53B | 6.23% |
| 2014-06-30 | $0.04B | $0.52B | 7.42% |
| 2014-03-31 | $0.04B | $0.51B | 7.89% |
| 2013-12-31 | $0.04B | $0.50B | 8.61% |
| 2013-09-30 | $0.04B | $0.47B | 8.72% |
| 2013-06-30 | $0.04B | $0.45B | 9.24% |
| 2013-03-31 | $0.04B | $0.44B | 10.04% |
| 2012-12-31 | $0.04B | $0.43B | 10.18% |
| 2012-09-30 | $0.05B | $0.41B | 12.18% |
| 2012-06-30 | $0.04B | $0.39B | 11.94% |
| 2012-03-31 | $0.04B | $0.38B | 12.33% |
| 2011-12-31 | $0.04B | $0.36B | 12.75% |
| 2011-09-30 | $0.04B | $0.34B | 10.53% |
| 2011-06-30 | $0.04B | $0.35B | 10.89% |
| 2011-03-31 | $0.03B | $0.33B | 11.09% |
| 2010-12-31 | $0.03B | $0.31B | 10.14% |
| 2010-09-30 | $0.03B | $0.30B | 9.13% |
| 2010-06-30 | $0.02B | $0.29B | 8.05% |
| 2010-03-31 | $0.02B | $0.29B | 7.30% |
| 2009-12-31 | $0.03B | $0.31B | 8.25% |
| 2009-09-30 | $0.03B | $0.31B | 9.44% |
| 2009-06-30 | $0.03B | $0.30B | 10.47% |
| 2009-03-31 | $0.03B | $0.29B | 10.48% |
| 2008-12-31 | $0.03B | $0.28B | 9.43% |
| 2008-09-30 | $0.02B | $0.27B | 8.63% |
| 2008-06-30 | $0.02B | $0.26B | 7.62% |
| 2008-03-31 | $0.02B | $0.25B | 6.84% |
| 2007-12-31 | $0.02B | $0.24B | 9.64% |
| 2007-09-30 | $0.03B | $0.25B | 10.03% |
| 2007-06-30 | $0.03B | $0.26B | 10.55% |
| 2007-03-31 | $0.03B | $0.25B | 12.12% |
| 2006-12-31 | $0.03B | $0.24B | 10.83% |
| 2006-09-30 | $0.02B | $0.24B | 10.41% |
| 2006-06-30 | $0.02B | $0.23B | 10.95% |
| 2006-03-31 | $0.02B | $0.22B | 11.03% |
| 2005-12-31 | $0.02B | $0.21B | 10.58% |
| 2005-09-30 | $0.01B | $0.19B | 7.26% |
| 2005-06-30 | $0.01B | $0.19B | 3.47% |
| 2005-03-31 | $0.00B | $0.17B | 2.35% |
| 2004-12-31 | $0.00B | $0.17B | 2.36% |
| 2004-09-30 | $0.01B | $0.17B | 7.68% |
| 2004-06-30 | $0.02B | $0.18B | 10.81% |
| 2004-03-31 | $0.02B | $0.17B | 11.76% |
| 2003-12-31 | $0.02B | $0.16B | 13.88% |
| 2003-09-30 | $0.02B | $0.16B | 13.40% |
| 2003-06-30 | $0.02B | $0.16B | 13.61% |
| 2003-03-31 | $0.02B | $0.16B | 14.67% |
| 2002-12-31 | $0.02B | $0.16B | 13.89% |
| 2002-09-30 | $0.02B | $0.15B | 14.18% |
| 2002-06-30 | $0.02B | $0.14B | 14.43% |
| 2002-03-31 | $0.02B | $0.13B | 14.72% |
| 2001-12-31 | $0.02B | $0.12B | 15.02% |
| 2001-09-30 | $0.02B | $0.11B | 14.93% |
| 2001-06-30 | $0.01B | $0.10B | 14.78% |
| 2001-03-31 | $0.01B | $0.10B | 14.44% |
| 2000-12-31 | $0.01B | $0.09B | 13.95% |
| 2000-09-30 | $0.01B | $0.09B | 13.50% |
| 2000-06-30 | $0.01B | $0.08B | 14.10% |
| 2000-03-31 | $0.01B | $0.08B | 13.42% |
| 1999-12-31 | $0.01B | $0.08B | 12.68% |
| 1999-09-30 | $0.01B | $0.07B | 11.81% |
| 1999-06-30 | $0.01B | $0.07B | 12.36% |
| 1999-03-31 | $0.01B | $0.07B | 12.90% |
| 1998-12-31 | $0.01B | $0.06B | 13.56% |
| 1998-09-30 | $0.01B | $0.06B | 14.22% |
| 1998-06-30 | $0.01B | $0.06B | 13.15% |
| 1998-03-31 | $0.01B | $0.06B | 11.94% |
| 1997-12-31 | $0.01B | $0.05B | 10.26% |
| 1997-09-30 | $0.00B | $0.05B | 10.06% |
| 1997-06-30 | $0.00B | $0.05B | 9.76% |
| 1997-03-31 | $0.00B | $0.05B | 9.47% |
| 1996-12-31 | $0.01B | $0.02B | 16.67% |
| 1996-09-30 | $0.01B | $0.05B | 15.69% |
| 1996-06-30 | $0.01B | $0.05B | 16.44% |
| 1996-03-31 | $0.01B | $0.00B | 19.51% |
| 1995-12-31 | $0.01B | $0.05B | 13.25% |
| 1995-09-30 | $0.00B | $0.05B | 12.40% |
| 1995-06-30 | $0.00B | $0.03B | 11.01% |
| 1995-03-31 | $0.00B | $0.03B | 11.43% |
| 1994-12-31 | $0.00B | $0.03B | 11.76% |
| 1994-09-30 | $0.00B | $0.03B | 12.00% |
| 1994-06-30 | $0.00B | $0.03B | 12.63% |
| 1994-03-31 | $0.00B | $0.03B | 13.19% |
| 1993-12-31 | $0.00B | $0.02B | 13.79% |
| 1993-09-30 | $0.00B | $0.02B | 14.63% |
| 1993-06-30 | $0.00B | $0.02B | 20.25% |
| 1993-03-31 | $0.00B | $0.02B | 21.33% |
| 1992-12-31 | $0.01B | $0.02B | 33.90% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.666B | $2.382B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $217.359B | 25.05 |
| EssilorLuxottica (ESLOY) | France | $151.069B | 0.00 |
| Boston Scientific (BSX) | United States | $138.964B | 31.78 |
| Stryker (SYK) | United States | $137.439B | 27.29 |
| Medtronic (MDT) | Ireland | $126.586B | 17.54 |
| Medline (MDLN) | United States | $57.028B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.992B | 0.00 |
| Agilent Technologies (A) | United States | $41.368B | 26.15 |
| GE HealthCare Technologies (GEHC) | United States | $38.856B | 18.58 |
| ResMed (RMD) | United States | $37.873B | 26.21 |
| Koninklijke Philips (PHG) | Netherlands | $28.984B | 18.93 |
| Terumo (TRUMY) | Japan | $21.172B | 23.83 |
| Insulet (PODD) | United States | $19.900B | 61.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.686B | 11.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.986B | 0.00 |
| Baxter (BAX) | United States | $10.199B | 8.23 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.585B | 30.87 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.350B | 13.25 |
| BillionToOne (BLLN) | United States | $4.319B | 0.00 |
| Envista Holdings (NVST) | United States | $3.979B | 22.83 |
| Haemonetics (HAE) | United States | $3.545B | 15.78 |
| Prestige Consumer Healthcare (PBH) | United States | $3.115B | 14.21 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.333B | 15.00 |
| Perrigo (PRGO) | Ireland | $2.045B | 5.12 |
| Neogen (NEOG) | United States | $2.043B | 44.71 |
| LeMaitre Vascular (LMAT) | United States | $1.939B | 39.02 |
| Curaleaf Holdings (CURLF) | Canada | $1.866B | 0.00 |
| AtriCure (ATRC) | United States | $1.858B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.734B | 76.00 |
| Phibro Animal Health (PAHC) | United States | $1.616B | 16.14 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.471B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.427B | 20.67 |
| Kestra Medical Technologies (KMTS) | United States | $1.302B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.170B | 347.00 |
| Capricor Therapeutics (CAPR) | United States | $1.133B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.112B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.007B | 0.00 |
| Omeros (OMER) | United States | $0.927B | 0.00 |
| Valneva SE (VALN) | France | $0.893B | 0.00 |
| InMode (INMD) | Israel | $0.887B | 10.03 |
| CeriBell (CBLL) | United States | $0.851B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.573B | 15.55 |
| Cerus (CERS) | United States | $0.526B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.486B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.483B | 0.00 |
| Brainsway (BWAY) | Israel | $0.461B | 78.50 |
| Canopy Growth (CGC) | Canada | $0.450B | 0.00 |
| SNDL (SNDL) | Canada | $0.428B | 0.00 |
| Quanterix (QTRX) | United States | $0.343B | 0.00 |
| Evolus (EOLS) | United States | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.291B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 22.06 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.241B | 142.00 |
| Sanuwave Health (SNWV) | United States | $0.241B | 0.00 |
| High Tide (HITI) | Canada | $0.228B | 0.00 |
| Organigram Global (OGI) | Canada | $0.218B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.206B | 0.00 |
| Accendra Health (ACH) | United States | $0.200B | 2.00 |
| Vireo Growth (VREOF) | United States | $0.197B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.189B | 16.64 |
| Quipt Home Medical (QIPT) | United States | $0.159B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.145B | 0.00 |
| Apyx Medical (APYX) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.77 |
| Exagen (XGN) | United States | $0.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.113B | 0.00 |
| Biote (BTMD) | United States | $0.109B | 4.76 |
| Sharps Technology (STSS) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.46 |
| Nephros (NEPH) | United States | $0.047B | 33.92 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.74 |
| Jin Medical (ZJYL) | China | $0.026B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |